A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now ...

Better U’s one-on-one doctor consultations and on-demand chat support ensure you don’t have to navigate your weight loss ...

Ilyce Glink, owner of Think Glink Media and Best Money Moves, joins WGN’s John Williams to give updates on the markets along ...

Wegovy is a prescription medication designed for chronic weight management, offering hope to individuals struggling with ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...

A Sayre man has pleaded guilty and faces up to more than 400 years in prison after he was arrested in 2024 on both meth and ...

Q. I have something like varicose veins in my nose that cause frequent nosebleeds. My nose is often dry regardless of weather conditions.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Pennsylvania’s natural gas industry has created jobs and lowered energy costs for people across Pennsylvania, but do they pay ...

A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.

Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete with popular GLP-1 agonists like Ozempic. It's called BRP (BRINP2-related ...